RNA constructs

Details for Australian Patent Application No. 2011265509 (hide)

Owner Devgen N.V.

Inventors Van De Craen, Marc; Plaetinck, Geert; Vercauteren, Isabelle; Logghe, Marc Georges; Bogaert, Thierry Andre Olivier Eddy; Zwaal, Richard

Agent Davies Collison Cave

Pub. Number AU-A-2011265509

Parent 2005298337

Filing date 22 December 2011

Wipo publication date 2 February 2012

International Classifications

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

Event Publications

19 January 2012 Complete Application Filed

2 February 2012 Application Open to Public Inspection

  Published as AU-A-2011265509

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011265510-Use of imidazoquinolines for the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members

2011265508-Poly (ethylene glycol) - diacrylate- (PEGDA) - crosslinked hydrogels comprising adipogenic mesenchymal stem cells